The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission

Carlos B. Mantilla, Leonid G. Ermilov

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Neurotrophin signaling at the neuromuscular junction modulates cholinergic transmission and enhances neuromuscular transmission via the tropomyosin-related kinase receptor subtype B (TrkB). A novel flavonoid, 7,8-dihydroxyflavone (7,8-DHF), selectively activates TrkB receptors. Using TrkBF616A mice that are susceptible to specific inhibition of TrkB activity by 1NMPP1, we show that neuromuscular transmission is enhanced by 7,8-DHF (∼32%) via activation of TrkB in diaphragm muscle. The small molecule 7,8-DHF may constitute a novel therapy to improve neuromuscular function.

Original languageEnglish (US)
Pages (from-to)274-276
Number of pages3
JournalMuscle and Nerve
Issue number2
StatePublished - Feb 2012


  • Flavones
  • Muscle fatigue
  • Neuromuscular transmission failure
  • Neurotrophins
  • Synaptic efficacy

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)


Dive into the research topics of 'The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission'. Together they form a unique fingerprint.

Cite this